Clinical Research Directory

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has active noninfectious intermediate uveitis, posterior uveitis, or panuveitis (NIIPPU) at screening and baseline in at least one eye * Meets prior stable dose and duration requirements before baseline for permitted immunosuppressive therapies and corticosteroids Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Has isolated anterior uveitis * Has macular edema as the only sign of intermediate, posterior, or panuveitis * Has active ocular disease that may confound assessment or is not adequately controlled * Has significant ocular comorbidity that would interfere with visualization or study assessments * Has planned ocular surgery during the double-masked treatment period * Has had recent ocular surgery or ocular laser procedure that could affect study assessments * Has had major surgery within 3 months prior to Screening or has major surgery planned during the study * Has a contraindication to mydriatic eye drops or cannot be adequately dilated for fundus - visualization * Has any condition preventing evaluation of both eyes for eligibility or efficacy assessments * Has any other immune-mediated inflammatory condition that is not well controlled and may require prohibited therapy * Has a transplanted organ requiring continued systemic immunosuppression * Has active infection * Has a recent history of malignancy that is not considered adequately resolved * Has had a recent diagnostic evaluation for malignancy where malignancy cannot be reasonably excluded * Has demonstrated intolerance to or prior inadequate response to high-dose oral corticosteroids for the study indication * Has known allergies, hypersensitivity, or intolerance to the study drug and other medications, dyes